• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ALLK

ALLK

Allakos Inc.

NASDAQHealthcareBiotechnologyUS

USD0.33

+0.00 (+0.22%)

Company Profile

CEO

Robert Alexander

IPO Date

2018-07-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.33

Prev. Close

$0.33

Day Low

$0.33

Day High

$0.33

52W Low

$0.22

52W High

$1.56

Market Cap

$0.03B

Volume

1.31M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

20.7%

Avg Negative

11.9%

Avg Neutral

67.4%

News Feed

3 Biotech Stocks That Could Double Soon

The Motley Fool·7/21/2021·↑ positive

Moving Average Crossover Alert: Allakos (ALLK)

Zacks Investment Research·6/7/2021·↓ negative

New Allakos Data Presented at DDW 2021 Suggest that Eosinophilic Gastritis and/or Eosinophilic Duodenitis (EG/EoD) is Highly Underdiagnosed and may be a Common Cause of Moderate-to-Severe Gastrointestinal Symptoms

GlobeNewsWire
·5/24/2021
·↑ positive

Bear Of The Day: Allakos (ALLK)

Zacks Investment Research·5/21/2021·↑ positive

7 of the Best Pharma Stocks to Buy Now

InvestorPlace·5/11/2021·↑ positive

Allakos Reports First Quarter 2021 Financial Results and Provides Business Update

GlobeNewsWire·5/10/2021·↑ positive

Allakos: Prevalence Data Shows A Large Undiagnosed Market

Seeking Alpha·3/21/2021·↑ positive

Are Options Traders Betting on a Big Move in Allakos (ALLK) Stock?

Zacks Investment Research·1/6/2021·↓ negative

Allakos Appoints Natalie Holles to its Board of Directors

GlobeNewsWire·12/22/2020·↑ positive

Allakos Reports Third Quarter 2020 Financial Results and Provides Business Update

GlobeNewsWire·11/9/2020·↑ positive